Magnetic Resonance Angiography
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical imaging technique
|
| gptkbp:abbreviation |
gptkb:MRA
|
| gptkbp:advantage |
Non-invasive
No radiation exposure |
| gptkbp:alternativeTo |
gptkb:Computed_Tomography_Angiography
Conventional angiography |
| gptkbp:canBe |
gptkb:Heart
gptkb:Brain Abdomen Neck Extremities Contrast agents Contrast-enhanced Non-contrast |
| gptkbp:compatibleWith |
gptkb:Ionizing_radiation
|
| gptkbp:contraindication |
Implanted metallic devices
Severe kidney disease (for contrast use) |
| gptkbp:contrastAgent |
gptkb:Gadolinium
|
| gptkbp:detects |
gptkb:Peripheral_artery_disease
Pulmonary embolism Carotid artery disease Aortic aneurysm Renal artery stenosis |
| gptkbp:developedBy |
1980s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Magnetic Resonance Angiography
|
| gptkbp:imagingModality |
Contrast-enhanced MRA
Phase-contrast Time-of-flight (TOF) |
| gptkbp:inventedBy |
Charles L. Dumoulin
Val Runge |
| gptkbp:limitation |
Claustrophobia risk
Longer scan time Motion sensitivity |
| gptkbp:relatedTo |
gptkb:Magnetic_Resonance_Imaging
gptkb:Computed_Tomography_Angiography Angiography Digital Subtraction Angiography |
| gptkbp:usedFor |
Assessing arteriovenous malformations
Detecting stenosis Detecting vascular diseases Evaluating aneurysms Visualizing blood vessels |
| gptkbp:usedIn |
Cardiology
Neurology Vascular surgery |
| gptkbp:uses |
gptkb:Magnetic_resonance_imaging
|
| gptkbp:visualizes |
Arteries
Veins |
| gptkbp:bfsParent |
gptkb:MRA
|
| gptkbp:bfsLayer |
8
|